Cargando…
In silico prediction of ARB resistance: A first step in creating personalized ARB therapy
Angiotensin II type 1 receptor (AT(1)R) blockers (ARBs) are among the most prescribed drugs. However, ARB effectiveness varies widely, which may be due to non-synonymous single nucleotide polymorphisms (nsSNPs) within the AT(1)R gene. The AT(1)R coding sequence contains over 100 nsSNPs; therefore, t...
Autores principales: | Anderson, Shane D., Tabassum, Asna, Yeon, Jae Kyung, Sharma, Garima, Santos, Priscilla, Soong, Tik Hang, Thu, Yin Win, Nies, Isaac, Kurita, Tomomi, Chandler, Andrew, Alsamarah, Abdelaziz, Kanassatega, Rhye-Samuel, Luo, Yun L., Botello-Smith, Wesley M., Andresen, Bradley T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725353/ https://www.ncbi.nlm.nih.gov/pubmed/33237899 http://dx.doi.org/10.1371/journal.pcbi.1007719 |
Ejemplares similares
-
From ARB to ARNI in Cardiovascular Control
por: Uijl, Estrellita, et al.
Publicado: (2016) -
Repurposing ARBs as treatments for breast cancer
por: George, Amee J., et al.
Publicado: (2017) -
The histological spectrum of ARB‐induced gastritis
por: Storozuk, Tanner, et al.
Publicado: (2022) -
Need to Revisit Step Therapy for ARBs
por: Ram, C. Venkata, et al.
Publicado: (2007) -
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)